General Dynamics Awarded Contract to Produce 20 Vehicles for Mine Resistant Vehicle Program

U.S. Marine Corps Systems Command (MCSC) has awarded General Dynamics Land Systems-Canada an $11 million delivery order to produce 20 vehicles for its Mine Resistant Ambush Protected (MRAP) vehicle program. This contract is in addition to an order announced earlier for four MRAP vehicles for test and evaluation.

Under this latest agreement, General Dynamics (NYSE: GD) will produce 10 Category I and 10 Category II MRAP vehicles. This Low Rate Initial Production (LRIP) order is being issued in advance of testing and full-scale production orders. With a stated requirement of 4,100 MRAP vehicles, General Dynamics continues to compete for the follow-on production orders.

The General Dynamics Land Systems-Canada MRAP vehicle is based on the RG-31 Mk5, the latest version of the highly successful RG-31 vehicle family. U.S. forces have previously ordered or received 424 RG-31 vehicles, including 265 Mk5s for the U.S. Army and Special Operations Command (SOCOM). The vehicles have proven to be highly effective against mines, improvised explosive devices and ballistic threats encountered by U.S. and Allied forces in both Iraq and Afghanistan.

"We are grateful for the opportunity to provide the U.S. military with a vehicle that has proven itself in operations," said Dr. Sridhar Sridharan, senior vice-president of General Dynamics Land Systems-Canada. "The feedback from U.S. and Canadian soldiers who have credited the RG-31 with saving lives is the best testament to its effectiveness."

The contract was signed through the Canadian Commercial Corporation, a Crown Agency of the Canadian Government.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.